Pharmacokinetics of Teicoplanin in a Patient with Coronavirus Disease 2019 Receiving Veno-venous Extracorporeal Membrane Oxygenation

INTRODUCTION: Patients with severe coronavirus disease 2019 (COVID-19) receiving ventilation or pulmonary support via veno-venous extracorporeal membrane oxygenation (VV-ECMO) can be infected with drug-resistant bacteria. When introducing VV-ECMO, the changes in serum antibiotic concentration should...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirayu, Nobuhisa, Nakamura, Atsuo, Morita, Toshio, Takasu, Osamu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sciendo 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682921/
https://www.ncbi.nlm.nih.gov/pubmed/36474610
http://dx.doi.org/10.2478/jccm-2022-0021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682921/
https://www.ncbi.nlm.nih.gov/pubmed/36474610
http://dx.doi.org/10.2478/jccm-2022-0021

Ejemplares similares